The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Scanlan International sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Scanlan International Inc (Scanlan) is a medical device company that designs and manufactures surgical instruments. The company’s product categories include instrumentation, instruments by specialty, instrument care and single-use products. It provides single-use products such as clamp jaw covers, graft markers, suture boots, suture tags, tunneler system, pin camps, and others. Scanlan’s instrumentation products comprise needle holders, titanium, bulldog clamps, clamps, forceps, scissors, sterilization trays and specialty instruments. The company’s instrument care product provides tracking and tagging system, sterilization trays, autoclavable pouch, color coding system, data matrix barcode tracking, and instrument protectors. Scanlan is headquartered in Saint Paul, Minnesota, the US.
The key metrics of Scanlan International related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Scanlan International is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Scanlan International.
For a detailed understanding of the performance of Scanlan International, buy the report here.